GGrantIndex
← Search

ADJUVANT COMPARISON AND CHARACTERIZATION

$3,018,059N01FY2024AINIH

Stanford University, Stanford CA

Investigators

Bali Pulendrancontact

Abstract

The goal of the Adjuvant Comparison and Characterization (ACC) program is to support side-by-side comparison of adjuvants in combination with clinically relevant vaccine/antigen platforms, and to establish both systemic and tissue-specific immunological profiles (“immune fingerprints”) of adjuvants that work through different mechanisms in the context of SARS-CoV-2 (COVID-19) vaccines.

View original record on NIH RePORTER →